Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Italy Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20053
20063
20073
20083
20096
20104
20113
20122
20136
20145
20156
20164
20173
20183
20195
20205
20212
20222
20233
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated15
Active, not recruiting8
Unknown status8
Recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
AstraZeneca4
Consorzio Oncotech4
Bayer3
ETOP IBCSG Partners Foundation3
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente3
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS3
Merck KGaA, Darmstadt, Germany3
Novartis Pharmaceuticals3
AGC Biologics S.p.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis81
Breast Neoplasms16
Neoplasms13
Colorectal Neoplasms11
Carcinoma, Non-Small-Cell Lung9
Recurrence9
Colonic Neoplasms7
Carcinoma, Renal Cell5
Rectal Neoplasms5
Lung Neoplasms4

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.